Zebra Capital Management LLC Celcuity Inc. Transaction History

Zebra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$5.1 - $7.07 $69,201 - $95,932	-13,569 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.42 - $11.04 $3,403 - $8,500	-770 Reduced 5.37%	13,569 $94,000
Q1 2020 May 15, 2020	SELL	$5.79 - $11.78 $5,946 - $12,098	-1,027 Reduced 6.68%	14,339 $93,000
Q4 2019 Feb 14, 2020	BUY	$9.47 - $16.71 $145,516 - $256,765	15,366 New	15,366 $163,000

30.1M

4.8K

126K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $235M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.